Elinzanetant

1 article tagged “Elinzanetant”

Learn

Elinzanetant (Lynkuet): The New Nonhormonal Hot Flash Drug

Lynkuet (elinzanetant) is the first dual NK1/NK3 antagonist for menopausal hot flashes. How it works, OASIS trial data, breast cancer use, cost, and HRT comparison.

All Topics

Women's HRT(37)Treatments(29)Protocols(28)Menopause(23)Safety(21)HRT(14)Comparisons(13)Timeline & Results(13)Fundamentals(13)Lab Testing(12)Clinics(12)Womens Hrt(11)Hormones(11)Dosing(11)Clinical Evidence(10)Perimenopause(9)Cardiovascular(8)Results(8)Regulation(6)Mood(5)Side Effects(5)Monitoring(5)Estrogen(5)Access(5)Libido(5)Body Composition(5)Symptoms(5)Estradiol(4)Research(4)Fertility(4)Fda(4)Injections(4)Treatment(4)Mental Health(4)Hot Flashes(3)News(3)Musculoskeletal(3)Diagnosis(3)Blood Work(3)Clinical Trials(3)Enclomiphene(3)Weight Loss(3)Cost(3)Pricing(3)Telehealth(3)Optimization(3)Peptides(3)Vasomotor Symptoms(2)Breast Cancer(2)Bloodwork(2)2026(2)Timing(2)Free Testosterone(2)Shbg(2)Womens Health(2)Bone Health(2)Prostate(2)Oral TRT(2)Cypionate(2)Pellets(2)Stacks(2)Sleep(2)Progesterone(2)Hematocrit(2)Insurance(2)Shortage(2)Testing(2)HCG(2)Reviews(2)Management(2)